Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 10019-945

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 10019-945). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclophosphamide Structural Formula (Image 01)

Chemical structure diagram of cyclophosphamide, showing a cyclic phosphate group connected to an amine and chlorinated ethyl side chains, with a hydrate (H2O) molecule indicated.*

FDA Label Image

Cyclophosphamide Premier Representative Container 10019-943-25 (Image 02)

Label for Cyclophosphamide injection, USP, 500 mg per vial, a powder for solution by Baxter Healthcare Company. Sterile, single-dose vial for intravenous or oral use. Instructions advise adding sterile water or sodium chloride injection to dissolve the drug. Manufactured by Baxter Healthcare Corporation in Deerfield, IL, made in Germany.*

FDA Label Image

Cyclophosphamide Premier Pro Representative Carton Label 10019-943-01 1 Of 2 (Image 03)

Cyclophosphamide for Injection, USP 500 mg vial label showing dosage form as injection powder for solution, manufactured by Baxter Healthcare Corporation. The label indicates use for IV infusion or direct injection, requiring dilution before administration. It highlights storage instructions, cytotoxic warning, and single-dose vial designation.*

FDA Label Image

Cyclophosphamide Premier Pro Representative Carton Label 10019-943-01 2 Of 2 (Image 04)

Packaging label for Cyclophosphamide for Injection, USP 500 mg per vial. The label specifies it is a prescription drug that must be diluted for IV infusion or direct injection use. It is a single-dose vial manufactured by Baxter Healthcare Corporation, Deerfield, IL, made in Germany, with trademark information for PremierProRx®.*

FDA Label Image

Cyclophosphamide Premier Representative Container Label 10019-944-50 (Image 05)

Label for Cyclophosphamide for Injection, USP, 1 gram vial, by Baxter Healthcare Company. The label indicates it is a cytotoxic agent for single-dose use, sterile, non-pyrogenic, for parenteral use. Instructions for IV infusion and direct injection preparation are provided, including diluents and shaking instructions. The product is made in Germany and includes storage guidance.*

FDA Label Image

Cyclophosphamide Premier Pro Representative Carton Label 10019-944-01 1 Of 2 (Image 06)

Packaging label for Cyclophosphamide for Injection, USP, 1 gram per vial, manufactured by Baxter Healthcare Company. This product is a single-dose vial that must be diluted for intravenous infusion or direct injection use. The label details storage instructions and preparation methods, including adding sterile water or sodium chloride for injection to dissolve the drug. It is identified as a cytotoxic agent for single-dose use and for parenteral administration.*

FDA Label Image

Cyclophosphamide Premier Pro Representative Carton Label 10019-944-01 2 Of 2 (Image 07)

Cyclophosphamide for Injection, USP 1 gram per vial packaging label. It is for intravenous infusion or direct injection use, single-dose vial. Manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA, made in Germany. The label includes NDC 10019-944-01 and notes that PremierProRx is a trademark of Premier Healthcare Alliance used under license.*

FDA Label Image

Cyclophosphamide Premier Representative Container Label 10019-945-10 (Image 08)

Label for Cyclophosphamide injection, USP, 2 gram per vial powder for solution. The label indicates it is a cytotoxic agent for single dose use, sterile and non-pyrogenic, for parenteral use only. Manufactured by Baxter Healthcare Corporation, Deerfield, IL, made in Germany. Instructions for reconstitution with sterile water or sodium chloride injection are included along with storage recommendations.*

FDA Label Image

Cyclophosphamide Premier Pro Representative Carton Label 10019-945-01 1 Of 2 (Image 09)

Packaging label for Cyclophosphamide for Injection, USP 2 gram/vial, a powder for solution injection, manufactured by Baxter Healthcare Corporation. The label indicates it must be diluted for IV infusion or direct injection use and is for single-dose vial use only. It includes directions for preparation, storage instructions, and warnings about cytotoxicity.*

FDA Label Image

Cyclophosphamide Premier Pro Representative Carton Label 10019-945-01 2 Of 2 (Image 10)

Packaging label for Cyclophosphamide for Injection, USP, 2 gram per vial, manufactured by Baxter Healthcare Corporation. The label indicates the drug must be diluted for IV infusion or direct injection use and contains 1 single dose vial. The label displays the NDC 10019-945-01 and notes the product is made in Germany.*

FDA Label Image

Representative Shipper Label 10019-943-01 (Image 11)

Label for CYCLOPHOSPHAMIDE Cyclophosphamide Injection, USP 500 mg by Baxter Healthcare Company. The label indicates storage at or below 25°C (77°F) and packaging of 120 packs, each containing one 500 mg single-dose vial. The NDC is 10019-943-01. Manufacturer details and barcodes are also shown.*

FDA Label Image

Representative Shipper Label 10019-944-01 (Image 12)

Packaging label for CYCLOPHOSPHAMIDE Cyclophosphamide for Injection, USP 1 g single dose vials. The label shows a pack containing 120 single-dose vials, each vial containing 1 g of the powder for solution used intravenously or orally. Manufactured by Baxter Healthcare Company with storage at or below 25°C (77°F). The label includes NDC 10019-944-01 and multiple barcodes.*

FDA Label Image

Representative Shipper Label 10019-945-01 (Image 13)

Label for CYCLOPHOSPHAMIDE injection, USP 2 g single dose vials in packs of 60 by Baxter Healthcare Company. The label includes storage instructions (store at or below 25°C), NDC 10019-945-01, batch and expiration placeholders, and multiple barcodes. Packaging specifies one 2 g vial per pack for intravenous or oral use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.